A comparison of treatment strategies for endometrial adenocarcinoma: Analysis of financial impact

被引:26
作者
Barnes, MN [1 ]
Roland, PY
Straughn, M
Kilgore, LC
Alvarez, RD
Partridge, EE
机构
[1] Univ Alabama, Dept Obstet & Gynecol, Div Gynecol Oncol, Birmingham, AL 35233 USA
[2] Northwestern Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Chicago, IL 60611 USA
关键词
D O I
10.1006/gyno.1999.5480
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The aim of this study was to investigate the influence of three treatment strategies for adenocarcinoma of the endometrium on the utilization of adjuvant radiation therapy and the medical charges associated with each pattern of practice. Methods. Three clinical algorithms felt to represent practice patterns for patients with endometrial cancer were considered: (1) comprehensive surgical staging of all patients, with adjuvant pelvic radiation reserved for documented cases of extrauterine disease, (2) total abdominal hysterectomy with bilateral salpingo-oophorectomy (TAH/BSO) with lymph node dissection reserved for cases of myometrial invasion, followed by adjuvant radiation based on the presence of uterine risk factors, and (3) TAH/BSO followed by intraoperative pathologic assessment of the uterus and consultation with a "surgical" oncologist for comprehensive staging. Each algorithm was applied to a cohort of 190 surgically staged patients identified through a retrospective medical records review. The use of radiation in each algorithm was quantified and the associated financial impact was estimated using hospital charges. Results. Treatment algorithm 1 yielded the lowest charges per patient at $12,778.52. Treatment algorithms 2 and 3 had associated charges per patient of $15,997.02 and $17,343.44, respectively. Conclusion. Approaches to care that lead to cost-effective utilization of health care resources should be pursued. (C) 1999 Academic Press.
引用
收藏
页码:443 / 447
页数:5
相关论文
共 19 条
  • [1] AALDERS J, 1980, OBSTET GYNECOL, V56, P419
  • [2] Endometrial carcinoma - Relative effectiveness of adjuvant irradiation vs therapy reserved for relapse
    Ackerman, I
    Malone, S
    Thomas, G
    Franssen, E
    Balogh, J
    Dembo, A
    [J]. GYNECOLOGIC ONCOLOGY, 1996, 60 (02) : 177 - 183
  • [3] BARAKAT RR, 1997, PRINCIPLES PRACTICE
  • [4] Surgical staging of endometrial cancer: Evolution, evaluation, and responsible challenge - A personal perspective
    Boronow, RC
    [J]. GYNECOLOGIC ONCOLOGY, 1997, 66 (02) : 179 - 189
  • [5] CREASMAN W, CANCER, V60, P2035
  • [6] Fanning James, 1998, Gynecologic Oncology, V68, P128
  • [7] FIGO (International Federation of Gynecology and Obstetrics), 1989, INT J GYNECOL OBSTET, V28, P189, DOI DOI 10.1016/0020-7292(89)90482
  • [8] PELVIC LYMPHADENECTOMY IN THE SURGICAL-TREATMENT OF ENDOMETRIAL CANCER
    GIRARDI, F
    PETRU, E
    HEYDARFADAI, M
    HAAS, J
    WINTER, R
    [J]. GYNECOLOGIC ONCOLOGY, 1993, 49 (02) : 177 - 180
  • [9] SELECTIVE PELVIC AND PERIAORTIC LYMPHADENECTOMY DOES NOT INCREASE MORBIDITY IN SURGICAL STAGING OF ENDOMETRIAL CARCINOMA
    HOMESLEY, HD
    KADAR, N
    BARRETT, RJ
    LENTZ, SS
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (05) : 1225 - 1230
  • [10] Cancer statistics, 1998
    Landis, SH
    Murray, T
    Bolden, S
    Wingo, PA
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1998, 48 (01) : 6 - +